New York State Common Retirement Fund Krystal Biotech, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 25,863 shares of KRYS stock, worth $4.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,863
Previous 28,381
8.87%
Holding current value
$4.13 Million
Previous $5.21 Million
9.67%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.3MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$631 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$455 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$419 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$232 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$158 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.1B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...